Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study

1. Martín, M.
2. Sánchez-Rovira, P.
3. Muñoz, M.
4. Baena-Cañada, J.M.
5. Mel, J.R.
6. Margeli, M.
7. Ramos, M.
8. Martínez, E.
9. García-Saenz, J.A.
10. Casado, A.
11. Jaén, A.M.
12. González-Farré, X.
13. Escudero, M.J.
14. Rodriguez-Martin, C.
15. Carrasco, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDR024 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus